Nancy Nixon

491 total citations
26 papers, 348 citations indexed

About

Nancy Nixon is a scholar working on Oncology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Nancy Nixon has authored 26 papers receiving a total of 348 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 8 papers in Immunology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Nancy Nixon's work include HER2/EGFR in Cancer Research (8 papers), Biosimilars and Bioanalytical Methods (6 papers) and Breast Cancer Treatment Studies (4 papers). Nancy Nixon is often cited by papers focused on HER2/EGFR in Cancer Research (8 papers), Biosimilars and Bioanalytical Methods (6 papers) and Breast Cancer Treatment Studies (4 papers). Nancy Nixon collaborates with scholars based in Canada, India and United Kingdom. Nancy Nixon's co-authors include Sunil Verma, Malek B. Hannouf, Scott Ernst, Christian Kollmannsberger, Michael Smylie, Normand Blais, Gwyn Bebb, Marcus O. Butler, Omar Khan and Isaiah MacDonald and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Nancy Nixon

25 papers receiving 345 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nancy Nixon Canada 10 233 85 69 64 45 26 348
Meagan S. Barbee United States 6 232 1.0× 82 1.0× 91 1.3× 71 1.1× 16 0.4× 8 331
Melinda Laine Hsu United States 11 214 0.9× 111 1.3× 119 1.7× 160 2.5× 31 0.7× 28 422
Karl Verpoort Germany 7 222 1.0× 123 1.4× 53 0.8× 64 1.0× 14 0.3× 10 370
Maria Silvia Cona Italy 8 279 1.2× 47 0.6× 90 1.3× 80 1.3× 74 1.6× 29 357
Amandine Quivy France 6 214 0.9× 73 0.9× 121 1.8× 83 1.3× 13 0.3× 9 351
Carmen Calfa United States 10 294 1.3× 70 0.8× 140 2.0× 76 1.2× 45 1.0× 40 406
Hakaru Tadokoro Brazil 10 369 1.6× 109 1.3× 237 3.4× 83 1.3× 42 0.9× 33 514
Blessie Elizabeth Nelson United States 10 126 0.5× 62 0.7× 47 0.7× 63 1.0× 26 0.6× 33 249
Robyn R. Young United States 10 260 1.1× 42 0.5× 152 2.2× 75 1.2× 23 0.5× 24 344
Éléonore De Guillebon France 9 335 1.4× 184 2.2× 116 1.7× 98 1.5× 18 0.4× 13 462

Countries citing papers authored by Nancy Nixon

Since Specialization
Citations

This map shows the geographic impact of Nancy Nixon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy Nixon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy Nixon more than expected).

Fields of papers citing papers by Nancy Nixon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nancy Nixon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy Nixon. The network helps show where Nancy Nixon may publish in the future.

Co-authorship network of co-authors of Nancy Nixon

This figure shows the co-authorship network connecting the top 25 collaborators of Nancy Nixon. A scholar is included among the top collaborators of Nancy Nixon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nancy Nixon. Nancy Nixon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nixon, Nancy, et al.. (2025). Breakfast clubs: a Yorkshire based review. Proceedings of The Nutrition Society. 84(OCE3).
2.
Raphael, Michael J., Monika Slovinec D’Angelo, Nancy Nixon, et al.. (2024). Addressing the Rising Trend in Early-Age-Onset Cancers in Canada. Current Oncology. 31(7). 4063–4078. 1 indexed citations
3.
Nixon, Nancy, et al.. (2023). Case report: Ultrahypofractionated palliative breast radiotherapy for a fungating invasive mammary carcinoma. Frontiers in Oncology. 13. 1171444–1171444. 2 indexed citations
4.
Abedin, Tasnima, Satbir Thakur, Haocheng Li, et al.. (2022). Abstract P1-08-01: Validation of automated Ki67 analysis to predict Oncotype DX recurrence score in early-stage breast cancer. Cancer Research. 82(4_Supplement). P1–8. 1 indexed citations
5.
Cuthbert, Colleen, Nancy Nixon, Michael M. Vickers, et al.. (2022). Top 10 research priorities for early-stage colorectal cancer: a Canadian patient-oriented priority-setting partnership. CMAJ Open. 10(1). E278–E287. 3 indexed citations
6.
Tang, Patricia A., et al.. (2022). A Review of Trastuzumab Biosimilars in Early Breast Cancer and Real World Outcomes of Neoadjuvant MYL-1401O versus Reference Trastuzumab. Current Oncology. 29(6). 4224–4234. 9 indexed citations
7.
Batra, Atul, Nancy Nixon, Malek B. Hannouf, et al.. (2021). Developing a clinical-pathologic model to predict genomic risk of recurrence in patients with hormone receptor positive, human epidermal growth factor receptor-2 negative, node negative breast cancer. Cancer Treatment and Research Communications. 28. 100401–100401. 3 indexed citations
8.
9.
Rydz, Natalia, et al.. (2021). Paraneoplastic acquired haemophilia A in extensive-stage small cell lung cancer (ES-SCLC) in the era of immunotherapy. BMJ Case Reports. 14(1). e236973–e236973. 2 indexed citations
10.
Clemons, Mark, Dean Fergusson, Anil A. Joy, et al.. (2020). A multicenter study comparing granulocyte-colony stimulating factors to antibiotics for primary prophylaxis of taxotere/cyclophosphamide-induced febrile neutropenia in patients with early-stage breast cancer.. Journal of Clinical Oncology. 38(15_suppl). 7001–7001. 1 indexed citations
11.
Nixon, Nancy, Christine Simmons, Julie Lemieux, & Sunil Verma. (2019). Research priorities in metastatic breast cancer: A James Lind Alliance Priority Setting Partnership. The Breast Journal. 26(3). 488–493. 6 indexed citations
12.
Ruzycki, Shannon M. & Nancy Nixon. (2018). Bone health after diagnosis of breast cancer. Canadian Medical Association Journal. 190(49). E1452–E1452. 1 indexed citations
13.
Ezeife, Doreen A., Derek S. Chew, Nancy Nixon, et al.. (2018). Economic analysis of osimertinib in previously untreated EGFR-mutant advanced non-small cell lung cancer in Canada. Lung Cancer. 125. 1–7. 26 indexed citations
14.
Nixon, Nancy, Normand Blais, Scott Ernst, et al.. (2018). Current Landscape of Immunotherapy in the Treatment of Solid Tumours, with Future Opportunities and Challenges. Current Oncology. 25(5). 373–384. 110 indexed citations
15.
Meyers, Daniel E., et al.. (2018). Aplastic anemia secondary to nivolumab and ipilimumab in a patient with metastatic melanoma: a case report. Experimental Hematology and Oncology. 7(1). 6–6. 25 indexed citations
16.
Nixon, Nancy, Malek B. Hannouf, & Sunil Verma. (2018). The Evolution of Biosimilars in Oncology, with a Focus on Trastuzumab. Current Oncology. 25(11). 171–179. 26 indexed citations
17.
Nixon, Nancy, Malek B. Hannouf, & Sunil Verma. (2017). A review of the value of human epidermal growth factor receptor 2 (HER2)-targeted therapies in breast cancer. European Journal of Cancer. 89. 72–81. 27 indexed citations
18.
Meyers, Daniel E., et al.. (2017). Tumour thrombus of the inferior vena cava extending into the right atrium in the setting of colon cancer. BMJ Case Reports. 2017. bcr2016218107–bcr2016218107. 5 indexed citations
19.
Nixon, Nancy, Omar Khan, Patricia A. Tang, et al.. (2017). Drug development for breast, colorectal, and non–small cell lung cancers from 1979 to 2014. Cancer. 123(23). 4672–4679. 17 indexed citations
20.
Nixon, Nancy & Sunil Verma. (2016). A Value-Based Approach to Treatment of HER2-Positive Breast Cancer: Examining the Evidence. American Society of Clinical Oncology Educational Book. 36. e56–e63. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Meagan S. Barbee Breakdown of academic impact, for papers by Melinda Laine Hsu Breakdown of academic impact, for papers by Karl Verpoort Breakdown of academic impact, for papers by Maria Silvia Cona Breakdown of academic impact, for papers by Amandine Quivy Breakdown of academic impact, for papers by Carmen Calfa Breakdown of academic impact, for papers by Hakaru Tadokoro Breakdown of academic impact, for papers by Blessie Elizabeth Nelson Breakdown of academic impact, for papers by Robyn R. Young Breakdown of academic impact, for papers by Éléonore De Guillebon
Rankless by CCL
2026